Real-world clinical utility in 1,112 patients tested with KidneyIntelX
KidneyIntelX stratification for cardiovascular risk in 1,278 diabetic kidney disease patients
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Real-world clinical utility in 1,112 patients tested with KidneyIntelX
KidneyIntelX stratification for cardiovascular risk in 1,278 diabetic kidney disease patients
Read more at globenewswire.com